Novo Nordisk A/S
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Novo Nordisk A/S's past years’ income statements indicate that its last revenue has increased compared to the previous period by 31% to $232,261,000,000. The net income raised on $83,683,000,000 and profit margin reached 36%. Total operating expenses were $93,922,000,000.

Profit Margin

Novo Nordisk A/S (NYSE:NVO): Profit margin
2014 88.80B 26.48B 29.82%
2015 107.92B 34.86B 32.3%
2016 111.78B 37.92B 33.93%
2017 111.69B 38.13B 34.14%
2018 111.83B 38.62B 34.54%
2019 122.02B 38.95B 31.92%
2020 126.94B 42.13B 33.19%
2021 140.8B 47.75B 33.92%
2022 176.95B 55.52B 31.38%
2023 232.26B 83.68B 36.03%

NVO Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
232.26B176.95B140.8B126.94B122.02B111.83B111.69B111.78B107.92B88.80B
Cost of revenue
35.76B28.44B23.65B20.93B20.08B17.61B17.63B17.18B16.18B14.56B
Gross profit
196.49B148.50B117.14B106.01B101.93B94.21B94.06B94.59B91.73B74.24B
Operating exp.
Research and development
32.44B24.04B17.77B15.46B14.22B14.80B14.01B14.56B13.60B13.76B
Selling and marketing
56.74B46.21B37.00B32.92B31.82B29.39B28.34B28.37B28.31B23.22B
Total operating expenses
93.92B73.69B58.49B51.88B49.45B46.96B45.09B46.16B42.29B39.75B
Operating income
102.57B74.80B58.64B54.12B52.48B47.24B48.96B48.43B49.44B34.49B
Other income (expenses), net
2.1B-5.74B436M-996M-3.93B473M-287M-536M-5.96B-396M
Income before tax
104.67B69.06B59.08B53.13B48.55B47.61B48.68B47.79B43.48B34.09B
Income tax expense
20.99B13.53B11.32B10.99B9.60B8.98B10.55B9.87B8.62B7.61B
Net income
83.68B55.52B47.75B42.13B38.95B38.62B38.13B37.92B34.86B26.48B
Earnings per share
Basic EPS
18.6212.2610.49.038.27.987.717.513.5610.1
Diluted EPS
18.6212.2210.3798.197.977.77.4813.5210.07
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source